The long-term outcome of 1390 children with acute lymphoblastic leukemia (ALL), treated in
two successive clinical trials (Taiwan Pediatric Oncology Group (TPOG)-ALL-97 and TPOG …

Abstract The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL)
Consortium has been conducting multi-institutional clinical trials in childhood ALL since …

The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium
Protocol 91-01 was designed to improve the outcome of children with newly diagnosed ALL …

Abstract The Dana-Farber Cancer Institute (DFCI) ALL consortium has been conducting
clinical trials in childhood acute lymphoblastic leukemia (ALL) since 1981. The treatment …

Abstract From 1984 to 2001, the Pediatric Oncology Group (POG) conducted 12 acute
lymphoblastic leukemia (ALL) studies. Ten-year event-free survival (EFS) for patients> 12 …

Abstract The Children's Cancer Group enrolled 13 298 young people age< 21 years on 1 of
16 protocols between 1983 and 2002. Outcomes were examined in three time periods, 1983 …

PURPOSE The goals of this treatment program were as follows: to improve event-free
survival (EFS) rates for high-risk (HR) patients by increasing the intensity of induction …

BACKGROUND AND OBJECTIVES: Treatment of childhood standard-risk (SR) acute
lymphoblastic leukemia (ALL) is generally successful. However, intensive chemotherapy …

The primary purpose of this study was to determine the therapeutic efficacy of a protocol of
treatment for acute lymphoblastic leukemia (ALL) in children. A prospective approach was …

Background To retrospectively determine the treatment outcome and causes of treatment
failure of ALL children treated in a single institution at East China. Procedure Between …